Protara Therapeutics is trading 17.4% up at $4.60 in pre-market, jumping from its July 31 close of $3.92 on light liquidity and speculative interest.
- There are no fresh company-specific headlines, earnings, regulatory updates, or major analyst calls tied to this move.
- The price action appears to be primarily driven by thin trading volume and broader risk-on sentiment in U.S. equity futures.